| Return to Contents in this Issue |
Practitioner's Corner |
|
Omalizumab: A Potential New Therapeutic Approach for Aspirin-Exacerbated Respiratory Disease |
|
I Bobolea,1 P Barranco,1 A Fiandor,1 R Cabañas,1 S Quirce1, 2 |
|
1 Allergy Department, Hospital
Universitario La Paz, Madrid, Spain |
|
J Investig Allergol Clin Immunol 2010; Vol. 20(5): 446-453 |
|
|

